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ABSTRACT
Objectives To identify barriers and enablers to participant 
retention in trials requiring questionnaire return using the 
theoretical domains framework (TDF).
Study design and setting We identified and subsequently 
invited participants who did not return at least one 
questionnaire during their participation in a clinical trial for 
one- to- one semi- structured telephone interviews. We used 
a behavioural framework (TDF) to explore whether any of 
the behavioural domains (eg, beliefs about consequences, 
emotion) affected questionnaire return. Thereafter, we 
generated a series of belief statements which summarised 
the content of participants’ main responses and coded 
these under separate themes.
Participants We distributed invites to 279 eligible 
individuals and subsequently interviewed 9 participants 
who took part in the C- Gall trial. The C- Gall trial required 
participants to complete five postal questionnaires during 
their participation.
Results Nine participants were interviewed. We 
developed 7 overarching themes which were relevant 
for returning postal questionnaires and identified both 
barriers and enablers from 11 core domains: knowledge; 
beliefs about consequences; environmental context 
and resources; reinforcement; emotion; beliefs about 
capabilities; behavioural regulation; social professional 
role and identity; skills; intentions and goals. Relevant 
content coded under these salient domains were 
categorised into seven key themes: unclear expectations 
of trial participation, personal attributes for questionnaire 
return, commitment to returning questionnaires given 
other priorities, sources of support in returning the 
questionnaires, individual preferences for presentation 
mode and timing of the questionnaires, internal and 
external strategies to encourage questionnaire return and 
the significance of questionnaire non- return.
Conclusion We demonstrate how a behavioural 
approach may be useful for clinical trials associated with 
significant participation burden (e.g. trials that require 
multiple questionnaire responses), acting as the essential 
groundwork for the development of appropriate evidence- 
based solutions to combat retention issues.
Trial registration number 55215960; Pre- results.
INTRODUCTION
Postal and electronic questionnaires are 
commonly used to obtain outcome data from 
participants within randomised controlled 
trials . While this method of data collection 
can be both practical and relatively inexpen-
sive, researchers often place heavy reliance 
on participants to successfully complete and 
return questionnaires. Trial retention rates 
drop when participants fail to return ques-
tionnaires, and this form of loss to follow- up 
poses a significant threat to the integrity of 
clinical trial findings. For example, in the 
presence of incomplete or lost questionnaire 
data, researchers are faced with the harsh 
reality that their findings may be tainted by 
a reduction in statistical power and the possi-
bility that their results are biased if partici-
pants who provide data differ in some way 
from non- responders.1 The challenges asso-
ciated with high attrition rates collectively 
undermine the extent to which clinical trial 
findings can guide the implementation of the 
best evidence- based healthcare interventions. 
The marked disadvantages associated with 
high attrition rates has led clinical unit trial 
directors across the UK to identify ‘methods 
to minimise attrition’ as a top priority.2
Strengths and limitations of this study
 ► We used an established theoretical framework to 
explore the factors that influence questionnaire non- 
response among clinical trial participants.
 ► It was difficult to engage trial non- responders and 
thus we recruited a small purposive sample (n=9).
 ► Findings, and the overall approach, will be useful 
for trialists to consider and adapt according to their 
clinical context.
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A recent survey conducted with key trial stakeholders 
to investigate the prioritisation of unanswered research 
questions around retention (the PRioRiTy II study) 
identified the number one ranked question as ‘What 
motivates a participant’s decision to complete a clinical 
trial?’3 Trial retention often involves several behaviours 
such as attending a clinic appointment or returning a 
questionnaire. Using a behavioural approach to investi-
gate the factors that influence retention appears to be a 
promising avenue for facilitating a science of retention. 
This approach would involve analysing the applicability 
and explanatory power of key concepts from behavioural 
science to the target behaviour which influences trial 
retention. Prior studies have adopted a behavioural lens 
to investigate the origins of other behaviours within clin-
ical trials, such as the implementation of a treatment arm 
and recruitment of participants.4 5 Yet, there is a marked 
absence of studies that adopt a behavioural science 
approach to investigate the factors that influence reten-
tion.6 7
In the present qualitative interview study, we aimed 
to uncover the factors that influenced questionnaire 
response rates using the theoretical domains framework 
(TDF) to investigate the barriers and enablers to question-
naire return within a clinical trial. The TDF is an estab-
lished framework that integrates 33 theories of behaviour 
into 14 domains that inhibit or enable behaviour (knowl-
edge, skills, social/professional role and identity, beliefs 
about capabilities, beliefs about consequences, opti-
mism, reinforcement, intentions, goals, memory/atten-
tion/decision processes, environmental context and 
resources, social influences, emotion and behavioural 
regulation).8 We applied the TDF within the design of 
this study to assess questionnaire return. The TDF was 
originally designed to understand and improve imple-
mentation of an intervention,9 and it has largely been 
applied to health professional behaviours.10–12 However, 
a growing body of literature has demonstrated the TDF’s 
application to the behaviour of the general public and 
patients.13 14 The current study extends this literature and 
demonstrates how the TDF can be applied to investigate 
patient behaviour within clinical trials.
METHODS
Design
This was a qualitative study, using semi- structured one- 
to- one interviews, which was embedded within the C- Gall 
clinical trial (ISRCTN: 55215960, see box 1). The topic 
guide (see online supplemental appendix 1) was informed 
by the TDF and refined by the research team and Public 
and Patient Involvement (PPI) members. In addition to 
interviews conducted as part of this embedded project, 
interviews conducted with C- Gall participants as part of a 
broader project (the Systematic Techniques to Enhance 
Retention in RCTs, STEER, study) exploring trial reten-
tion across several trials including C- Gall were also 
included in this study during analysis.15 The STEER study 
developed the topic guide for use in the interviews. The 
topic guide was iteratively updated to ensure robustness.
Patient and public involvement
As part of the STEER study, two public partners reviewed 
the interview topic guide to ensure the questions were 
clear and acceptable for the purpose of the study. Patients 
or the public were not actively involved in the reporting 
or dissemination plans of the research.
Participants
We invited a purposive sample of participants who had 
not returned at least one questionnaire at any time point 
during the study, and therefore had discontinued their 
follow- up at least once. An invitation letter and partici-
pant information leaflet were distributed to all potential 
participants with a reply slip and a prepaid envelope. A 
researcher (JD/RN) then contacted interested partici-
pants to discuss the study further and book a mutually 
convenient time for a telephone interview. All invita-
tion packs were distributed from the C- Gall trial office 
to maintain the confidentiality of potential participants. 
Two attempts were made to engage with potential partic-
ipants. One hundred and sixty- five C- Gall participants 
were invited to participate in this phase of the interview 
study and an earlier 114 had been invited as part of the 
STEER study.
Data collection
Interviews were conducted by RN (academic researcher, 
female, age 40 years) and JD (research assistant, female, 
age 25 years) to explore participants’ experiences of the 
trial, reasons for not returning questionnaires and the 
behavioural barriers and facilitators to questionnaire 
return. Data collection was conducted between January 
and November 2019. Participants were made aware that 
the interviewers were neither clinicians nor involved in 
the day- to- day conduct of the C- Gall trial. The researchers 
obtained verbal informed consent from participants. All 
interviews were audio- recorded and transcribed verbatim 
by an external transcribing service. We judged the suffi-
ciency of our sample size against five key aspects of infor-
mation power: whether the study aim is broad or narrow 
(with a focused aim requiring a smaller sample); dense or 
sparse sample specificity (where dense specificity requires 
a smaller sample); application or not of established theory 
(theoretical perspectives requiring smaller sample); 
quality of the dialogue (with strong clear communication 
Box 1 Description of the C- Gall trial
The C- Gall trial is a randomised controlled trial comparing laparoscopic 
cholecystectomy with conservative management for preventing recur-
rent symptoms and complications in adults with uncomplicated symp-
tomatic gallstones. Participation in the trial includes completing five 
postal questionnaires at: 3, 6, 9, 12 and 24 months.
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requiring less); and finally, whether case or cross- case 
analysis (with cross- case requiring more participants).16
Data analysis
A TDF coding guide was used to aid interpretation: this 
was developed and iteratively updated during the coding 
process (RN, LL, EMD, KG). Three of the nine interview 
transcripts were triple coded independently (LL, KG, 
EMD) prior to comparing the coding results. The few 
coding discrepancies identified during this process were 
discussed to reach consensus. Specialist input from a TDF 
expert (EMD) was used to resolve coding disagreements 
in instances where it was difficult to reach a consensus. 
One researcher (LL) coded all participants’ interview 
responses into the relevant theoretical domains.
After coding data into theoretical domains, belief 
statements were generated (LL) which represented 
similar underlying beliefs held by participants within 
each domain.17 Belief statements were designed to 
elicit detail on the role of each domain in influencing 
the behaviour (questionnaire return). Statements were 
worded to capture multiple utterances that conveyed a 
similar meaning. Specific beliefs that centralised on the 
same theme or represented the opposite were grouped 
together under the same statement.
We used the recommended procedure for TDF anal-
ysis to identify the relevant domains that were most likely 
to influence the behaviour17: (1) the frequency of belief 
statements across all domains; (2) the presence and prev-
alence of conflicting beliefs; and (3) evidence of strong 
beliefs that influence the behaviour. All three criteria 
were considered concurrently to judge the relevance of 
each domain. We developed overarching themes that 
described the content of related belief statements and 
domains to effectively summarise the findings. Overar-
ching themes were initially generated by LL who assessed 
the belief statements across all domains and categorised 
them into separate themes. These themes and belief 
statements were refined by KG and EMD to ensure that 
they summarised the data accurately.
RESULTS
Sample characteristics
Nine participants in total were recruited. All interview 
participants were participating in the C- Gall trial at the 
time of interview, six were recruited specifically for the 
purposes of the C- Gall trial substudy and three recruited 
via the STEER study. Participant demographics are 
provided in table 1. This is comparable to the entire 
population of C- Gall trial non- responders (in February 
2020) whom were 79.4% women and 20.6% men with a 
median age of 51. The length of interviews ranged from 
25 min to 1 hour 28 min (median=36 min).
Overall findings
The following sections describe the domains that were 
relevant to the target behaviour (questionnaire return). 
Domains and associated belief statements were catego-
rised into overarching themes to summarise the main 
messages arising from the data. A total of seven themes 
were identified. These were: unclear expectations of 
trial participation; personal attributes for questionnaire 
completion; commitment to returning questionnaires 
given other priorities; the significance of questionnaire 
non- return; individual preferences for presentation mode 
and timing of the questionnaires; internal and external 
strategies to encourage questionnaire return and sources 
of support in returning the questionnaires. Each of these 
themes will be presented in detail below. An extended 
table containing the frequency of the TDF domains and 
belief statements is provided in online supplemental 
appendix 2. Figure 1 represents a visual illustration of the 
findings. A summary table of the findings is also presented 
in online supplemental appendix 3.
Theme 1: unclear expectations of trial participation
The majority of participants reported being unaware 
of the duration of their participation within the trial, 
although some indicated a certain level of awareness of 
their ongoing participation.
I think at the appointment initially, they said that the 
trial had been extended. They didn’t give me a time-
frame for how long it would go on for. (Participant 1)
Importantly, participants suggested that the activities 
involved in the trial did not meet their initial expectations, 
with some indicating that they expected a greater level 
of medical attention, such as support and information 
provided to help manage their condition, such as dietary 
advice, among participants randomised to conservative 
management.
I’m not sure if it’s just myself or if other people are on 
the same, medical management (conservative man-
agement), a little bit more information, a little bit 
more contact with someone asking, ‘How are you do-
ing? Have you received this information?’ or just giv-
ing information out would help a bit more. I’m not 
sure if it’s… if you don’t do it, I didn’t know that med-
ical management was just filling in questionnaires. I 
thought there’d be a little bit more to it, that’s all. 
(Participant 8)
Most participants indicated that they did not perceive 
the questions within the questionnaire as relevant to their 
circumstances. This was because they were either not expe-
riencing pain at the time of receiving the questionnaire or 
Table 1 Sample characteristics
Characteristic (n/9)
Gender
  Male 2/9
  Female 7/9
Median age (years, range) 53 years (35–75 years)
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because they had been assigned to conservative manage-
ment and therefore did not receive gallstone surgery and 
regarded the questions as irrelevant.
Well, there were a few. I mean, I started off well and 
then because nothing had happened… I hadn’t had 
any pain or anything and then I’d put them aside and 
then somebody would send another one and say, ‘You 
haven’t completed it’. (Participant 2)
Participants also reported confusion over receiving the 
same questionnaire on multiple occasions. As they did not 
expect to receive (or understand the purpose of) iden-
tical questionnaires at different time points, they did not 
send some of the questionnaires back to the trial office.
Theme 2: personal attributes for questionnaire completion
The majority of participants recognised that there were 
certain skills required to complete the questionnaires, 
such a remembering the level of pain experienced over a 
certain amount of time.
No, I suppose you have to be able to read, you have 
to be able to understand, take the time and compre-
hend what it’s asking you as well. And also, to rec-
ollect, to recall when you’ve gone to the doctors, all 
that sort of thing, you know? (Participant 7)
Some also acknowledged that completing the question-
naire required concentration, and sometimes this was 
reported as a barrier to completion and return.
I suppose if the questions had been really complicat-
ed or difficult to answer, maybe. Or if you just can’t 
remember what exactly has happened over the time. I 
suppose the time between questionnaires, if it’s every 
three months then that’s not too bad, but if it was lon-
ger than that then I’d definitely have trouble remem-
bering exactly what symptoms I’d had and how many 
times and all the fine details. (Participant 1)
Theme 3: the significance of questionnaire non-return
Participants reported feelings of guilt triggered by ques-
tionnaire non- return. This was mostly linked to the belief 
that they were letting the trial team down and having a 
negative effect on trial results.
It’s been playing on my mind that I haven’t done it 
yet. Not willing me but making me angry with my-
self for not doing it…For messing up the trials. 
(Participant 3)
Around half of the participants reported a sense of 
satisfaction brought about by successfully completing and 
returning the questionnaires and felt it was their duty to 
complete this task as a trial participant. Feelings of satis-
faction were mostly linked to their beliefs about conse-
quences: that their contribution would help the research.
Well, you’ve completed a job, you know that it’s im-
portant, it helps in clinical trials, it’s helping find-
ing out stuff. That’s the upside of doing it, and you 
feel satisfaction, that you’re making a difference. 
(Participant 4)
Theme 4: commitment to returning the questionnaires given 
other priorities
Some participants suggested that they were not committed 
to performing the behaviour because they did not prior-
itise completion and return among other duties and 
Figure 1 Overarching themes and associated TDF domains. ECR, environmental context and resources; SPRI, social 
professional role and identity; TDF, theoretical domains framework.
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responsibilities. Sometimes participants reported being 
too busy to schedule in completion and return.
The questionnaire thing for me is a barrier because 
I’ll think, ‘Oh, I’ll put it to the side, I’ll do it when I’ve 
got time,’ and I never get the time. I’ve got my second 
one to fill and it’s been there for months. Really bad! 
(Participant 2)
On the contrary, a few participants stated their commit-
ment to completing the questionnaires because they had 
agreed to take part in the trial and they recognised the 
negative consequences of not returning the question-
naires, such as wasting the researcher’s time.
Well, I want to return it so it is quite important, be-
cause then I’m wasting your time and money by you 
sending these forms out if I’m not going to bother. 
(Participant 9)
Theme 5: individual preferences for presentation mode and 
timing of the questionnaires
Preference for questionnaire format differed among 
participants: some regarded postal administration as 
convenient for them, others indicated that they would 
have preferred to speak to someone or complete the 
questionnaire electronically.
I much preferred it when I could give oral answers 
to a simplified version in which she said, “These are 
just the main questions that we need to know.” That 
didn’t take nearly as long, and it was quite focused 
and straightforward. (Participant 2)
Some participants linked their preference for 
completing the questionnaire with a trial member of staff 
to their social personality. The majority of participants 
perceived the questionnaire to be boring, and most indi-
cated that if it were a lengthy questionnaire, they would 
struggle to complete it.
It wasn’t very interesting, it was pretty boring. 
(Participant 3)
Theme 6: internal and external strategies to encourage 
questionnaire return
Some participants indicated strategies that they had 
used to help them complete the questionnaires. These 
included ‘internal’ strategies such as making a plan to 
complete and return the questionnaires and keeping a 
note of symptoms to ensure accurate reporting.
I would actually think, “Well, I’ve got to get this done” 
and do it and then send it off. Saying that, yes, prob-
ably… You’re right, I would probably say, “Oh, I’m 
going to sit down this evening, fill this questionnaire 
in and then get it sent off’.” So, yes, in that way, there 
was a plan. (Participant 5)
Some participants indicated that they completed the 
questionnaires whenever they had spare time and would 
often complete the questionnaire as soon as they received 
it to avoid forgetting about it.
Yes, like I say, once I received it, I filled it in and on 
the way to pick my son up from school I put it in a 
post box. (Participant 8)
Participants also mentioned external strategies to 
encourage questionnaire return. The majority of partic-
ipants reported that they did not expect to receive any 
incentives or rewards for completing and returning the 
questionnaires, and for one participant rewards/incen-
tives offered would have been perceived as a form of 
bribery:
Yeah, I just want to do it because I want to do it. I 
don’t really want anybody to try and bribe me to do 
it or encourage me to do it due to any kind of incen-
tive, no. In some ways, actually, that would put me off. 
(Participant 3)
Most participants suggested that they would have liked 
to receive a prompt or reminder to complete and return 
the questionnaires.
It’s an extra thing that we volunteered to do, I could 
have just said no to my surgery anyway and not gone 
for this, do you understand what I mean, because I 
had that choice. But I went for this and I volunteered 
for it, just that little bit of a reminder and a bit of 
support, “We’re helping you out on this, it’s okay, I 
know it’s late but can you try and get it in now. Or do 
you want to come and see me?” There’s a few more 
options. That’s it. (Participant 6).
However, one participant indicated that they had 
received a friendly reminder from the trial office and 
believed it to be effective because it was not communi-
cated in a forceful manner.
I think once I didn’t return it and they sent me out a 
reminder questionnaire, which was good. It wasn’t a 
telling off, but it was just a reminder that it was there. 
That was good if you know what I mean…Yeah, with-
out being forceful, kind of thing. (Participant 4)
Theme 7: sources of support in returning the questionnaires
A couple of participants reported that they received 
support from family members to return the question-
naires, while the majority indicated that they completed 
and returned the forms independently. All participants 
indicated that they received some level of support from 
the trial office to complete trial- related activities. This 
included receiving gentle reminders or facilitating ques-
tionnaire completion over the phone with a trial staff 
member.
Once I’ve filled it in, my husband supports me in 
terms of he gets it to you, as in he posts it for me be-
cause I don’t go out to post it when I’ve got work or 
whatever. But that’s the only support…my husband 
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is understanding. He understands the pain and he 
helps me when I’m suffering and stuff, but no, I don’t 
have any other support, not really. (Participant 6)
Participants suggested that they did not feel any pres-
sure to complete and return the questionnaires, and for 
some this was a barrier to questionnaire completion and 
return.
No, I’ve got no pressures from anyone. Nobody en-
courages me either. At first, my sister half encouraged 
me to take part because I was about 90% sure I was 
going to do it, and then after talking to her and a 
couple of others, just things that were said I just said, 
“Yeah, I’ll do it”. (Participant 1)
DISCUSSION
This study investigated trial retention using a behavioural 
science approach: we applied a theoretical framework to 
understand the barriers and enablers to questionnaire 
return within a clinical trial. Obtaining maximum ques-
tionnaire response rates is essential to maintain scientific 
validity, reduce bias and optimise trial rigour. Our find-
ings suggest that many behavioural domains from the 
TDF were relevant and important for influencing ques-
tionnaire return and as such this behavioural approach 
lent itself well to the problem of trial retention. We believe 
the TDF was particularly suited to investigating the factors 
that influence questionnaire return, given that this is a 
very specific behaviour characterised by low complexity. 
This allowed us to isolate the factors that influence this 
specific behaviour. These findings may be transferable to 
other trials with postal questionnaires used as a mecha-
nism for data collection, however, it may be difficult to 
apply the findings of the current study to other trial reten-
tion behaviours, such as attending a clinic appointment. 
Identifying the relevant influential domains within the 
TDF is an essential stage required prior to developing 
behaviour change interventions designed to improve 
retention.
One of the most frequently reported barriers to ques-
tionnaire return was related to the fact that the trial did 
not meet the participants’ expectations, either because 
they expected to receive additional medical attention or 
they did not understand how the questionnaire related 
to their circumstances (e.g. due to a lack of pain/symp-
toms experienced or because they had not undergone 
surgery). Some studies suggest that it is not uncommon 
for trial staff to communicate inaccuracies about the 
timing and delivery of study questionnaires within initial 
clinical trial consultations, and the right to withdraw is 
sometimes highlighted without explaining the associated 
negative consequences.18 Likewise, a recent study demon-
strated that withdrawal and retention is often poorly 
described within participant information leaflets.19 Our 
study suggests that retention may drop when expecta-
tions are violated, particularly when a mismatch exists 
between the initial briefing of the trial and participants’ 
actual experience. This highlights the importance of 
managing expectations, clarifying the activities involved 
within the trial and how this relates to study outcomes. 
Relatedly, many participants acknowledged that ques-
tionnaire completion required concentration, engaged 
memory processes and demanded literacy and communi-
cation skills. It may be helpful for trial staff to outline the 
requirements of trial activities in terms of the expected 
duration and methods participants can use to facilitate 
questionnaire return.
Participants reported a mixed level of commitment 
devoted to completing and returning the questionnaire, 
with some indicating high levels of commitment due 
to the recognised consequences of failing to return the 
questionnaires, while others admitted that their lack of 
commitment to completing the questionnaires influ-
enced memory and prioritisation. In a study assessing 
techniques to increase retention in a behavioural weight 
loss trial, one technique deployed involved communi-
cating the consequences of trial drop- out to participants, 
which included how attrition might bias findings.20 This 
appeared to be an effective method of increasing reten-
tion and could be a technique applied to increase motiva-
tion and commitment to clinical trials.
In terms of social support, a few participants indi-
cated that their family members helped them to return 
the questionnaires whereas others suggested that they 
completed and returned the questionnaires inde-
pendently. Although not necessarily perceived to be a 
barrier to retention within this study, some studies indicate 
that a lack of social support influences retention- related 
behaviours, such as erratic clinic attendance.21 It may be 
useful for trial staff to be mindful of the importance of 
social support for each participant, and where unavail-
able, offer additional support to those who require it, 
particularly those who may have physical/mental disabil-
ities that hinder trial participation. Providing support to 
participants where required may also help to ensure that 
trials are more inclusive.
In response to questions related to questionnaire 
format, participants reported mixed preferences: some 
indicated that postal administration was ideal, whereas 
others suggested that they preferred to complete the 
questionnaire electronically or over the phone. It may be 
helpful for trial staff to ask participants their preferred 
mode of questionnaire delivery, and while it may not be 
practical to tailor the administration format for each 
participant, it could reduce the number of reminders 
required for distribution and enhance retention. It is 
also important to note that there may be generational 
differences in preferences for questionnaire format, 
where older adults may be more likely to prefer paper- 
based or telephone forms as opposed to electronic 
versions.22 Likewise, some individuals may not have 
access to electronic devices and considerations of digital 
poverty should be taken into account. Tailoring the 
mode of administration to participants’ preferences and 
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circumstances may help to include the groups of people 
that are commonly under- represented in UK medical 
research.23
Participants reported mixed strategies used to support 
questionnaire return, which included internal strategies 
that represented personal behavioural regulatory prac-
tices used to facilitate behaviour, such as making a plan to 
complete and return the questionnaires and maintaining 
a diary of symptoms to simplify questionnaire comple-
tion. External strategies reported to be helpful included 
reminders distributed from the trial office. This finding 
supports the evidence which suggests that the use of 
electronic prompts can improve questionnaire response 
rates.24 Contrary to the evidence which suggests the 
effectiveness of monetary incentives,25 participants indi-
cated that incentives or rewards would have actually been 
perceived as a form of bribery and would deter participa-
tion from the trial. Participants are likely to have different 
preferences for the type of reward/incentive received, 
and these need to be designed carefully to ensure that 
they are not coercive and do not encourage trial partici-
pation for the wrong reasons.26
We have demonstrated how a behavioural approach can 
be applied to assess the factors that influence a key trial 
retention behaviour: return of a postal questionnaire. 
We performed a behavioural diagnosis which is the first 
stage of designing TDF informed interventions that can 
improve retention. Effective interventions often contain 
behaviour change techniques (BCTs) that comprise the 
‘active ingredients’ designed to elicit change. By assessing 
the relevance of each behavioural domain within the 
TDF, effective BCTs can be matched and incorporated 
within the intervention to facilitate behaviour change.9 
One study has demonstrated how a theory informed 
cover letter containing BCTs can improve retention.7 
Another study suggests that is not uncommon for studies 
to apply BCTs implicitly in an effort to elicit change and 
improve trial participation.6 Our study suggests that an 
in- depth qualitative analysis can be useful for identi-
fying participant- relevant BCTs that can be considered 
to improve retention. We have designed a TDF informed 
cover letter and newsletter with embedded BCTs that 
are likely to be effective based on the interview findings 
reported within this paper. These will be distributed to 
C- Gall trial participants in an effort to boost the ques-
tionnaire return rate. We have also outlined practical 
considerations other researchers may wish to take into 
account to increase questionnaire return rate, such as 
managing participants’ expectations of trial- related activ-
ities (e.g. how many questionnaires they will be expected 
to complete), highlighting the negative consequences 
of participant drop- out, tailoring the administration of 
questionnaires to suit individual preferences and circum-
stances and providing support where required. These 
adjustments are similar to the recommendations outlined 
in a recent paper.27
Strengths and weaknesses
We used a validated theoretical framework to guide the 
design and analysis phases of this qualitative study. It was 
appropriate to use the TDF in this instance because we 
were investigating the barriers and enablers to conducting 
a specific retention- related behaviour: questionnaire 
return. Although we distributed invites to over 300 poten-
tial participants, we only secured 9 interview participants. 
Our sample size was relatively small as it was difficult to 
engage trial non- retainers. It is possible that additional 
themes may have emerged if we had interviewed more 
participants. However, given our findings resonate with 
other literature on participant reported reasons for chal-
lenges in trial retention,28 we believe many of the key 
factors were identified. We were also satisfied that our 
sample size was sufficient as no new concepts were iden-
tified within the TDF domains over the last three inter-
views. This is in line with stopping criterion for theory 
informed interviews and the guidance on information 
power.16 Nevertheless, our findings may be limited to a 
particular trial context, specifically those that require 
participants to respond to several questionnaires. Other 
trials may require participants to attend a follow- up 
clinic appointment or to adhere to certain medication. 
The applicability of our findings may not necessarily be 
extended to other non- retention behaviours.
Conclusion
Our study uncovers the common barriers and enablers 
to return of postal questionnaires in clinical trials 
using a behavioural framework. We demonstrate how 
a behavioural approach may be particularly useful for 
clinical trials associated with significant participation 
burden (e.g. trials that require multiple questionnaire 
responses), acting as the essential groundwork for the 
development of appropriate evidence- based solutions to 
combat retention issues. Findings will serve as a guiding 
framework when designing trials to limit barriers and 
enhance enablers of retention, complementing host trial 
data and contributing to improving trial methodology.
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